Want to see FLGT full AI Analyst Report?
Fulgent Genetics (FLGT) Income Statement
Fulgent Genetics Income Statement
Last quarter (Q2 2026), Fulgent Genetics's total revenue was $85.39M, an increase of 4.38% from the same quarter last year. In Q2, Fulgent Genetics's net income was $-29.53M. See Fulgent Genetics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 322.67M | $ 283.47M | $ 289.21M | $ 618.97M | $ 992.58M | |
| $ 130.88M | $ 107.22M | $ 104.46M | $ 366.90M | $ 777.05M | |
| $ 221.97M | $ 181.13M | $ 299.99M | $ 188.37M | $ 101.10M | |
| Depreciation and Amortization | $ 24.12M | $ 24.93M | $ 26.14M | $ 32.66M | $ 11.00M |
| $ -45.83M | $ -26.86M | $ -147.45M | $ 217.70M | $ 692.04M | |
| $ -91.10M | $ -73.92M | $ -195.53M | $ 178.53M | $ 675.95M | |
| $ 21.07M | $ 21.96M | $ 21.44M | $ 5.50M | $ 5.08M | |
| $ -70.03M | $ -51.96M | $ -174.09M | $ 184.03M | $ 681.03M | |
| $ -60.51M | $ -42.71M | $ -167.82M | $ 143.40M | $ 507.36M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.97 | $ -1.41 | $ -5.63 | $ 4.76 | $ 17.13 |
| Diluted EPS | $ -1.97 | $ -1.41 | $ -5.63 | $ 4.63 | $ 16.26 |
| Weighted Average Shares Outstanding | 30.78M | 30.23M | 29.78M | 30.10M | 29.41M |
| Weighted Average Shares Outstanding (Diluted) | 30.78M | 30.23M | 29.78M | 30.96M | 30.98M |
Currency in USD